Active Ingredient History
Cord blood is blood that remains in the placenta and in the attached umbilical cord after childbirth. Cord blood is collected because it contains stem cells, which can be used to treat hematopoietic and genetic disorders such as cancer. There is growing interest from cell therapeutics companies in developing genetically modified allogenic natural killer cells from umbilical cord blood as an alternative to CAR T cell therapies for rare diseases. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Aplastic (Phase 4)
Anemia, Sickle Cell (Phase 2)
Autism Spectrum Disorder (Phase 1/Phase 2)
Autistic Disorder (Phase 1/Phase 2)
beta-Thalassemia (Phase 2)
Bone Marrow Cells (Phase 1)
Bone Marrow Failure Disorders (Phase 2)
Bone Marrow Transplantation (Phase 1)
Cerebral Palsy (Phase 1/Phase 2)
Child Development (Phase 1/Phase 2)
Corneal Diseases (Phase 1/Phase 2)
Efficiency (Phase 1)
Fetal Blood (Phase 1)
Heart Arrest, Induced (Phase 2)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemoglobinopathies (Phase 2)
Hodgkin Disease (Phase 3)
Immune System Diseases (Phase 1)
Infusions, Intravenous (Phase 2)
Ischemic Stroke (Phase 1)
Leukemia (Phase 2)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Monocytic, Acute (Phase 1)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 1)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Metabolic Diseases (Phase 2)
Metabolism (Phase 1)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Neoplasms (Phase 1)
Neuroblastoma (Phase 1)
Osteopetrosis (Phase 2)
Pediatrics (Phase 1)
Primary Myelofibrosis (Phase 2)
Progeria (Phase 1/Phase 2)
Severe Combined Immunodeficiency (Phase 1/Phase 2)
Spinal Cord Injuries (Phase 1/Phase 2)
Stem Cell Transplantation (Phase 1)
Transplantation (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
